Rakovina Therapeutics Inc. (TSXV:RKV)
Canada
· Delayed Price · Currency is CAD Rakovina Therapeutics Statistics
Total Valuation
TSXV:RKV has a market cap or net worth of CAD 15.84 million. The enterprise value is 17.15 million.
| Market Cap | 15.84M |
| Enterprise Value | 17.15M |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:RKV has 21.11 million shares outstanding. The number of shares has increased by 43.35% in one year.
| Current Share Class | 21.11M |
| Shares Outstanding | 21.11M |
| Shares Change (YoY) | +43.35% |
| Shares Change (QoQ) | +40.47% |
| Owned by Insiders (%) | 2.50% |
| Owned by Institutions (%) | n/a |
| Float | 18.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.62 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.12 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.39, with a Debt / Equity ratio of 0.58.
| Current Ratio | 0.39 |
| Quick Ratio | 0.06 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.28 |
Financial Efficiency
Return on equity (ROE) is -206.27% and return on invested capital (ROIC) is -80.64%.
| Return on Equity (ROE) | -206.27% |
| Return on Assets (ROA) | -69.36% |
| Return on Invested Capital (ROIC) | -80.64% |
| Return on Capital Employed (ROCE) | -217.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.57% in the last 52 weeks. The beta is -0.23, so TSXV:RKV's price volatility has been lower than the market average.
| Beta (5Y) | -0.23 |
| 52-Week Price Change | -28.57% |
| 50-Day Moving Average | 0.53 |
| 200-Day Moving Average | 1.05 |
| Relative Strength Index (RSI) | 65.68 |
| Average Volume (20 Days) | 36,911 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.21M |
| Pretax Income | -5.50M |
| Net Income | -5.50M |
| EBITDA | -4.67M |
| EBIT | -5.21M |
| Earnings Per Share (EPS) | -0.62 |
Balance Sheet
The company has 75,819 in cash and 1.39 million in debt, giving a net cash position of -1.31 million or -0.06 per share.
| Cash & Cash Equivalents | 75,819 |
| Total Debt | 1.39M |
| Net Cash | -1.31M |
| Net Cash Per Share | -0.06 |
| Equity (Book Value) | 2.39M |
| Book Value Per Share | 0.17 |
| Working Capital | -1.45M |
Cash Flow
| Operating Cash Flow | -4.83M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:RKV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.35% |
| Shareholder Yield | n/a |
| Earnings Yield | -34.73% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 24, 2025. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jun 24, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |